Medtronic Acquires Glucose Monitoring Assets from PreciSense

///Medtronic Acquires Glucose Monitoring Assets from PreciSense

Medtronic Acquires Glucose Monitoring Assets from PreciSense

GlobalData’s report, “Medtronic Acquires Glucose Monitoring Assets from PreciSense: A Move to Develop New Platform for Closed Loop System” provides key information and analysis on Medtronic’s acquisition of PreciSense. The report provides information on deal rationale that includes Medtronic’s closed loop system and global market sizing for Continuous Glucose Monitoring (CGM) system.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope:

  • Annualized market revenue data for global Continuous Glucose Monitoring (CGM) systems market for 2009 and forecast forward to 2016.
  • Qualitative analysis on Medtronic’s acquisition of PreciSense.

Reasons to buy:

  • Develop business strategies by understanding the trends and developments that are driving the global CGM systems market
  • Understand the key technologies that are expected to drive the CGM systems market in the future
  • Exploit M&A opportunities by identifying key areas of growth
  • Make more informed business decisions from the insightful and in-depth analysis of the global CGM systems market and the factors shaping it
By |2019-02-03T18:47:25+00:00July 16th, 2013|Diabetes News, News|2 Comments

About the Author:

Leave A Comment